Chemical and biological conjugation strategies for the development of multivalent protein vaccine nanoparticles.

Autor: Park J; School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA., Pho T; School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.; BioEngineering Program, Atlanta, Georgia, United States., Champion JA; School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.; BioEngineering Program, Atlanta, Georgia, United States.
Jazyk: angličtina
Zdroj: Biopolymers [Biopolymers] 2023 Aug; Vol. 114 (8), pp. e23563. Date of Electronic Publication: 2023 Jul 25.
DOI: 10.1002/bip.23563
Abstrakt: The development of subunit vaccine platforms has been of considerable interest due to their good safety profile and ability to be adapted to new antigens, compared to other vaccine typess. Nevertheless, subunit vaccines often lack sufficient immunogenicity to fully protect against infectious diseases. A wide variety of subunit vaccines have been developed to enhance antigen immunogenicity by increasing antigen multivalency, as well as stability and delivery properties, via presentation of antigens on protein nanoparticles. Increasing multivalency can be an effective approach to provide a potent humoral immune response by more strongly engaging and clustering B cell receptors (BCRs) to induce activation, as well as increased uptake by antigen presenting cells and their subsequent T cell activation. Proper orientation of antigen on protein nanoparticles is also considered a crucial factor for enhanced BCR engagement and subsequent immune responses. Therefore, various strategies have been reported to decorate highly repetitive surfaces of protein nanoparticle scaffolds with multiple copies of antigens, arrange antigens in proper orientation, or combinations thereof. In this review, we describe different chemical bioconjugation methods, approaches for genetic fusion of recombinant antigens, biological affinity tags, and enzymatic conjugation methods to effectively present antigens on the surface of protein nanoparticle vaccine scaffolds.
(© 2023 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: